Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy
Authors
Keywords
-
Journal
Nanomedicine-Nanotechnology Biology and Medicine
Volume 32, Issue -, Pages 102333
Publisher
Elsevier BV
Online
2020-11-12
DOI
10.1016/j.nano.2020.102333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy
- (2019) Xinyu Ye et al. ACS Nano
- Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
- (2019) Dean A. Lee IMMUNOLOGICAL REVIEWS
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- NK-Cell-Encapsulated Porous Microspheres via Microfluidic Electrospray for Tumor Immunotherapy
- (2019) Dan Wu et al. ACS Applied Materials & Interfaces
- Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade
- (2019) Laila Belcaid et al. ACTA CLINICA BELGICA
- Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
- (2019) Yao Liu et al. Nano-Micro Letters
- Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination
- (2018) Rong Yang et al. ACS Nano
- Cell Membrane Coating Nanotechnology
- (2018) Ronnie H. Fang et al. ADVANCED MATERIALS
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
- (2018) Diego Sanchez-Martinez et al. Theranostics
- Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
- (2018) Robert W. Wilkinson et al. Frontiers in Immunology
- NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
- (2018) Vedrana Jelenčić et al. NATURE IMMUNOLOGY
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer
- (2018) Valsamo Anagnostou et al. CANCER RESEARCH
- Electrospray Synthesis of Poly(lactide-co-glycolide) Nanoparticles Encapsulating Peptides to Enhance Proliferation of Antigen-Specific CD8 + T Cells
- (2017) Britta Furtmann et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
- (2017) Liya Zhu et al. Theranostics
- Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
- (2016) Haiqiang Cao et al. ACS Nano
- Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
- (2016) Ashley V. Kroll et al. BIOCONJUGATE CHEMISTRY
- Selection and expansion of natural killer cells for NK cell-based immunotherapy
- (2016) Petra S. A. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- NK cells and type 1 innate lymphoid cells: partners in host defense
- (2016) Hergen Spits et al. NATURE IMMUNOLOGY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Prospects for gene-engineered T cell immunotherapy for solid cancers
- (2016) Christopher A Klebanoff et al. NATURE MEDICINE
- Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma
- (2015) N. W. C. J. van de Donk et al. BLOOD
- Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
- (2015) Naoyuki Sakamoto et al. Journal of Translational Medicine
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
- (2015) Ronnie H. Fang et al. Small
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
- (2014) Ronnie H. Fang et al. NANO LETTERS
- Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy
- (2014) Daniel Landi et al. Frontiers in Oncology
- Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
- (2012) Christopher A Alvarez-Breckenridge et al. NATURE MEDICINE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More